Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Elevated expression of a subset of interferon inducible genes in primary bone marrow cells expressing p185 Bcr-Abl versus p210 Bcr-Abl by DNA microarray analysis.

Leukemia research - 1 Mar 2004

Advani Anjali S, Dressman Holly K, Quiroz Marisol, Taylor Gregory A, Pendergast Ann Marie

Abstract excerpt

p185 Bcr-Abl has a more aggressive biological/clinical leukemia phenotype than p210 Bcr-Abl. In this study, we examined differential gene expression using microarrays to determine if upregulation or downregulation of specific genes may explain the distinct phenotypes produced by the two Bcr-Abl forms. RNA was collected from mouse bone marrow mononuclear cells expressing equivalent levels of p185 or p210, and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow Cells
Share to Fusion Proteins, bcr-abl

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Leukemic

Share to GTP Phosphohydrolases

Share to Interferon-gamma

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Molecular Weight

Share to Protein Isoforms

Source

Identifiers

PMID: 14687624
DOI: 10.1016/s0145-2126(03)00264-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Elevated expression of a subset of interferon inducible genes in primary bone marrow cells expressing p185 Bcr-Abl versus p210 Bcr-Abl by DNA microarray analysis.PMID 14687624Read ↗

Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.Semantic proximity Read ↗

Identification of transcriptional targets associated with the expression of p210 Bcr-Abl.Semantic proximity Read ↗

Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomicsSemantic proximity Read ↗

BCR/ABL P210 and P190 cause distinct leukemia in transgenic miceSemantic proximity Read ↗

Genomic Mechanisms of p210BCR-ABL SignalingSemantic proximity Read ↗

BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemias.Semantic proximity Read ↗

The P190, P210, and P230 Forms of the <i>BCR/ABL</i> Oncogene Induce a Similar Chronic Myeloid Leukemia–like Syndrome in Mice but Have Different Lymphoid Leukemogenic ActivitySemantic proximity Read ↗

The 5' non-coding region of the BCR/ABL oncogene augments its ability to stimulate the growth of immature lymphoid cells.Semantic proximity Read ↗

Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach.Semantic proximity Read ↗

Down-regulation of BRCA1 in BCR-ABL–expressing hematopoietic cellsSemantic proximity Read ↗

Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2Semantic proximity Read ↗

Expression of p210 and p190 BCR‐ABL due to alternative splicing in chronic myelogenous leukaemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.